NCT01242930Phase 2Completed

Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma

Study sponsor: Geron Corporation

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2014-11Actual
Enrollment · participants13Actual
Source updated2026-06-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.